These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 8874594)
21. Biomagnification of cycad neurotoxins in flying foxes: implications for ALS-PDC in Guam. Banack SA; Cox PA Neurology; 2003 Aug; 61(3):387-9. PubMed ID: 12913204 [TBL] [Abstract][Full Text] [Related]
22. Cycad neurotoxins, consumption of flying foxes, and ALS-PDC disease in Guam. Cox PA; Sacks OW Neurology; 2002 Mar; 58(6):956-9. PubMed ID: 11914415 [TBL] [Abstract][Full Text] [Related]
23. Epidemiological characteristics of motor neuron disease in Chinese patients. Cui F; Liu M; Chen Y; Huang X; Cui L; Fan D; Pu C; Lu J; Zhou D; Zhang C; Yan C; Li C; Ding X; Liu Y; Li X; Jiang Y; Zhang J; Shang H; Yao X; Ding Y; Niu Q; Wang L Acta Neurol Scand; 2014 Aug; 130(2):111-7. PubMed ID: 24689740 [TBL] [Abstract][Full Text] [Related]
24. Epidemiological and clinical patterns of western pacific amyotrophic lateral sclerosis (ALS) in Guam and sporadic ALS in Rochester, Minnesota, U.S.A. and Hokkaido, Japan: a comparative study. Okumura H Hokkaido Igaku Zasshi; 2003 May; 78(3):187-95. PubMed ID: 12795170 [TBL] [Abstract][Full Text] [Related]
25. The ALS/PDC syndrome of Guam and the cycad hypothesis. Borenstein AR; Mortimer JA; Schellenberg GD; Galasko D Neurology; 2009 Feb; 72(5):473, 476; author reply 475-6. PubMed ID: 19188582 [No Abstract] [Full Text] [Related]
26. Seeking environmental causes of neurodegenerative disease and envisioning primary prevention. Spencer PS; Palmer VS; Kisby GE Neurotoxicology; 2016 Sep; 56():269-283. PubMed ID: 27050202 [TBL] [Abstract][Full Text] [Related]
27. Familial Madras motor neuron disease (FMMND): study of 15 families from southern India. Nalini A; Yamini BK; Gayatri N; Thennarasu K; Gope R J Neurol Sci; 2006 Dec; 250(1-2):140-6. PubMed ID: 17010382 [TBL] [Abstract][Full Text] [Related]
28. Nationwide incidence of motor neuron disease using the French health insurance information system database. Kab S; Moisan F; Preux PM; Marin B; Elbaz A Amyotroph Lateral Scler Frontotemporal Degener; 2017 Aug; 18(5-6):426-433. PubMed ID: 28387141 [TBL] [Abstract][Full Text] [Related]
29. The Guam cycad toxin methylazoxymethanol damages neuronal DNA and modulates tau mRNA expression and excitotoxicity. Esclaire F; Kisby G; Spencer P; Milne J; Lesort M; Hugon J Exp Neurol; 1999 Jan; 155(1):11-21. PubMed ID: 9918700 [TBL] [Abstract][Full Text] [Related]
30. Age-dependent sex ratios of motor neuron disease: French nationwide study and meta-analysis. Ahmadzai P; Kab S; Vlaar T; Artaud F; Carcaillon-Bentata L; Canonico M; Moisan F; Elbaz A Neurology; 2018 May; 90(18):e1588-e1595. PubMed ID: 29602909 [TBL] [Abstract][Full Text] [Related]
31. Geographical epidemiology of residence of patients with motor neuron disease in Lancashire and south Cumbria. Mitchell JD; Gatrell AC; Al-Hamad A; Davies RB; Batterby G J Neurol Neurosurg Psychiatry; 1998 Dec; 65(6):842-7. PubMed ID: 9854959 [TBL] [Abstract][Full Text] [Related]
32. Urolithiasis, Urinary Cancer, and Home Drinking Water Source in the United States Territory of Guam, 2006-2010. Haddock RL; Olson DR; Backer L; Malilay J Int J Environ Res Public Health; 2016 May; 13(6):. PubMed ID: 27231922 [TBL] [Abstract][Full Text] [Related]
33. Clinical heterogeneity of familial motor neuron disease: report of 11 pedigrees from a population based study in Scotland. The Scottish Motor Neuron Disease Research Group. Chancellor AM; Fraser H; Swingler RJ; Holloway SM; Warlow CP J Neurol Sci; 1994 Jul; 124 Suppl():75-6. PubMed ID: 7807151 [TBL] [Abstract][Full Text] [Related]
34. Patterns of acquiring parkinsonism-dementia complex on Guam. 1944 through 1985. Zhang ZX; Anderson DW; Lavine L; Mantel N Arch Neurol; 1990 Sep; 47(9):1019-24. PubMed ID: 2396931 [TBL] [Abstract][Full Text] [Related]
35. The ALS/PDC syndrome of Guam and the cycad hypothesis. Cruz-Aguado R; Shaw CA Neurology; 2009 Feb; 72(5):474, 476; author reply 475-6. PubMed ID: 19195085 [No Abstract] [Full Text] [Related]
36. TDP-43 pathology in familial frontotemporal dementia and motor neuron disease without Progranulin mutations. Seelaar H; Schelhaas HJ; Azmani A; Küsters B; Rosso S; Majoor-Krakauer D; de Rijk MC; Rizzu P; ten Brummelhuis M; van Doorn PA; Kamphorst W; Willemsen R; van Swieten JC Brain; 2007 May; 130(Pt 5):1375-85. PubMed ID: 17360763 [TBL] [Abstract][Full Text] [Related]
37. Clinical features and changing patterns of neurodegenerative disorders on Guam, 1997-2000. Galasko D; Salmon DP; Craig UK; Thal LJ; Schellenberg G; Wiederholt W Neurology; 2002 Jan; 58(1):90-7. PubMed ID: 11781411 [TBL] [Abstract][Full Text] [Related]
38. Cancer in Guam and Hawaii: A comparison of two U.S. Island populations. Hernandez BY; Bordallo RA; Green MD; Haddock RL Cancer Epidemiol; 2017 Oct; 50(Pt B):199-206. PubMed ID: 29120826 [TBL] [Abstract][Full Text] [Related]
39. Creating a Simian Model of Guam ALS/PDC Which Reflects Chamorro Lifetime BMAA Exposures. Banack SA; Cox PA Neurotox Res; 2018 Jan; 33(1):24-32. PubMed ID: 28478528 [TBL] [Abstract][Full Text] [Related]
40. An epidemic-like cluster of motor neuron disease in a Swedish county during the period 1973-1984. Gunnarsson LG; Lygner PE; Veiga-Cabo J; de Pedro-Cuesta J Neuroepidemiology; 1996; 15(3):142-52. PubMed ID: 8700306 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]